One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fibrosis. The technique, known as genomewide karyomapping, was capable of not only detecting diseases caused by a specific gene mutation, in this case cystic fibrosis, but that it was also capable of detecting aneuploidy (an abnormal number of any of the 23 pairs of chromosomes) at the same time.

Read the original here: 
New Test Can Detect Both Genetic And Chromosomal Abnormalities In Embryos

Popularity: 2%

You may also like:

• New Fluorescent Silicon Nanoparticles Discovered
• Orange Juice Worse For Teeth Than Whitening Agents, Study Finds
• New CATCH rule to determine need for CT scans in children with minor head injury
• New tools and systems may help patients, primary care clinicians manage obesity
• Cancer Predisposition From Particular Genetic Variation Shows Strong Gender Bias
• New Evidence That Green Tea May Help Improve Bone Health
• New Method Can Predict 80 Percent Of Cases Of Postnatal Depression
• Scientists Identify Gene For Short-circuiting Excess Mucus In Lung Disease, Common Colds
• Gene Variant Heightens Risk Of Severe Liver Disease In Cystic Fibrosis
• New Technique Can Help Diagnose Mesothelioma